National Natural Science Foundation of China(Grant No.21172014,812111023 and 81172733);grants from the Ministry of Science and Technology of China(Grant No.200 9ZX09301-010)
Three series of novel anti-immunodeficiency virus 1 (HIV-1) dual (RT/1N) inhibitors were rationally designed by introducing a functioning diketo acid (DKA) into pyridin-2-one scaffold. To efficiently analyze inh...
supported by grants from the State Key Laboratory of Infectious Disease Prevention and Control(2011SKLID102);the National Nature Science Foundation of China(81172733 and 81561128006);the 12th Five-Year National Science and Technology Major Project(2013ZX10001-006)
Objective To investigate distinctive features in drug-resistant mutations (DRMs) and interpretations for reverse transcriptase inhibitors (RTIs) between proviral DNA and paired viral RNA in HIV-l-infected patients...
supported by grants from State Key Laboratory for Infectious Disease Prevention and Control(2011SKLID102);National Nature Science Foundation of China(81172733)
The success of combined antiretroviral therapy (cART) has dramatically improved the clinical outcomes of HIV infection and made HIV infection a chronic disease. Nonetheless, cART alone cannot eliminate viral reservo...